We found 1 drugmaker program for Alpha-1 Antitrypsin Deficiency medicines and 2 charity funds (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Alpha-1 Antitrypsin Deficiency depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Insurance premiums and copays.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
PROLASTIN-C LIQUID: commercially insured patients may qualify for $0 copay via PROLASTIN DIRECT Assist, with help up to $10,000 per year.
PROLASTIN DIRECT: automatic enrollment; insurance verification, delivery, home infusion nurses and connection to AlphaNet coordinators.
GLASSIA or ARALAST NP: Takeda Co-Pay Assistance Program can cover up to 100% of copay for eligible commercially insured patients; annual maximum applies.
Takeda Patient Support: insurance help, pharmacy coordination and home infusion training for GLASSIA and ARALAST NP.
ZEMAIRA Connect case managers do benefit checks; enrollment is required for CSL Behring financial help. Phone 1-866-936-2472.
Four brands, three companies, each with its own program. Takeda Patient Support: 1-866-888-0660. ZEMAIRA Connect: 1-866-936-2472. Takeda's copay excludes Medicare, Medicaid, TRICARE, VA and state programs. ZEMAIRA copay terms are not published on an official page; ask CSL Behring directly. PROLASTIN DIRECT enrollment is through your doctor's form.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 1 drugmaker program for Alpha-1 Antitrypsin Deficiency medicines and 2 charity funds, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Alpha-1 Antitrypsin Deficiency, 0 charity funds on this page accept Medicare, and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, NORD RareCare's Alpha-1 Antitrypsin Deficiency Premium Copay Assistance fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
None of the drugmaker programs for Alpha-1 Antitrypsin Deficiency medicines on this page says it gives free medicine to people without insurance. Their support lines can still check what you qualify for. Most charity funds need some insurance.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (NORD RareCare, The Assistance Fund) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
